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Wei Zhou, MD, Peter H. Lin, MD, Ruth L. Bush, MD, Liz Nguyen, MD, and Alan B. Lumsden, MD,
Houston, Tex
Purpose: Cocaine-induced arterial thrombosis is uncommon, and most reported cases involved small-diameter vessels such
as the cerebral and coronary arteries. This study was undertaken to review our experience with peripheral arterial
thrombosis presumed caused by cocaine abuse.
Methods: Hospital records were reviewed for all patients admitted over 10 years with acute arterial occlusion involving the
peripheral arterial system. Patients with confirmation of cocaine use or of its derivative, crack cocaine, within 24 hours of
hospital admission formed the basis of this study. Symptoms at presentation, management, and outcome in these patients
were reviewed.
Results: Three hundred eighty-two patients with acute peripheral arterial occlusion were identified during the study
period. The presumptive diagnosis of cocaine-induced arterial occlusion was made in 5 patients (4 men, mean age 38
years). Cocaine use was achieved via intranasal inhalation in 2 patients (40%), whereas the 3 remaining patients smoked
crack cocaine (60%). The mean time between cocaine use and onset of arterial thrombosis was 9.2 hours (range, 2-20
hours). Symptoms at presentation included acute limb ischemia without pedal Doppler signals (3 patients, 60%) and
abdominal pain without femoral pulses (2 patients, 40%). Arterial occlusion was confirmed on angiograms in all patients,
which revealed aortic thrombosis in 1 patient (20%), iliac thrombosis in 2 patients (40%), superficial femoral artery
thrombosis in 1 patient (20%), and popliteal artery occlusion in 1 patient (20%). Surgical thrombectomy was successfully
performed in 4 patients (80%), and 1 patient (20%) underwent successful thrombolytic therapy for femoropopliteal artery
occlusion. There was no perioperative mortality. All 5 patients who were discharged were available for follow-up (mean,
36 months; range, 6-75 months). There was 1 late death from myocardial infarction. In 1 patient recurrent lower
extremity arterial thrombosis developed after 28 months, which was successfully treated with thrombolytic therapy.
Conclusions: Our study underscores cocaine abuse as a potential cause of acute arterial thrombosis. Cocaine-induced
arterial thrombosis should be suspected in patients with recent history of cocaine abuse with acute limb ischemia without
an identifiable source or overt cardiovascular risk factors. Prompt angiography with operative or endovascular interven-
tion should be performed to avert arterial ischemic sequelae. (J Vasc Surg 2004;40:291-5.)For many centuries coca leaves were considered an
important herbal medicine among the South American
native Indians residing in high-altitude terrain, who regu-
larly chewed coca leaves to achieve a euphoric effect.1 Over
the past century, however, coca leaves have been routinely
processed to produce cocaine powder, which is a highly
addictive and commonly used illicit drug in the United
States. It is currently estimated that more than 4 million
persons in the United States use cocaine regularly, of which
1 million persons are clinically addicted to cocaine or its
derivate, crack cocaine.2
Habitual consumption of cocaine can result in serious
health hazards, particularly involving the cardiovascular
system. More than 20% of patients who go to emergency
rooms because of cocaine overdose had symptoms relating
to the cardiovascular system.3 Cocaine-induced cardiovas-
cular complications are well documented, and include myo-
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doi:10.1016/j.jvs.2004.04.026cardial ischemia, cardiac arrhythmia, aneurysm rupture,
aortic dissection, endocarditis, and deep venous thrombo-
sis.4-8 In contrast, cocaine-induced arterial thrombosis is
uncommon, and most reported cases involve small-diame-
ter vessels such as the cerebral and coronary arteries.2,9
Arterial thrombosis involving peripheral vasculature is even
rarer, and has been documented in only 3 case reports.10-12
In this study we report our experience in patients with
peripheral arterial thrombosis associated with consumption
of cocaine or its derivative, crack cocaine. Symptoms at
presentation, management, and outcomes in these patients
are reported.
MATERIALS AND METHODS
From January 1992 to June 2003, hospital records for
all patients treated at Baylor College of Medicine–affiliated
hospitals because of an acute arterial thromboembolic
event were reviewed. These hospitals included the Meth-
odist Hospital, the Ben Taub General Hospital, and the
Houston Veterans Affairs Medical Center. Particular atten-
tion was paid to the temporal relationship between illicit
drug use and the onset of thromboembolic episodes. Pa-
tients with confirmation of cocaine use or of its derivative,
crack cocaine, within 24 hours of hospital admission
formed the basis of this study. In contrast, patients with
certain risk factors associated with thromboembolic pro-291
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included known arterial embolic sources, such as aortic
aneurysm or valvular heart disease; documented cardiac risk
factors, such as atrial fibrillation; and proved hypercoagu-
lable states. Data were collected with respect to timing and
route of cocaine usage, clinical presentation and diagnostic
findings of arterial thrombosis, and intervention and treat-
ment outcome. Long-term data were obtained from clini-
cal or hospital records or by telephone interview with the
patient or the primary physician.
RESULTS
Three hundred eighty-two patients with acute periph-
eral arterial occlusion were identified during the study
period. A presumptive diagnosis of cocaine-induced arterial
occlusion was made in 5 patients (Table I), who included 4
men and 1 woman, with mean age of 38 years (range,
26-49 years). Cocaine use was via intranasal inhalation in 2
patients (40%), whereas the remaining 3 patients smoked
crack cocaine (60%). The mean time between cocaine use
and onset of arterial thrombosis was 9.2 hours (range, 2-20
hours). The mean history of cocaine usage was 3.4 years
(range, 0.8-7 years). In addition to using cocaine or its
derivatives, all 5 patients had used other illicit narcotic
drugs (Table I). No patient had a history or family history
of thromboembolism.
Symptoms at presentation included acute lower limb
ischemia without pedal Doppler signals (3 patients, 60%)
and abdominal pain without femoral pulses (2 patients,
40%). In contrast, palpable femoral, popliteal, and pedal
pulses were noted in the contralateral leg in all 5 patients.
Arterial occlusion was confirmed at angiography in all
patients, which revealed aortic thrombosis in 1 patient
(20%), iliac thrombosis in 2 patients (40%), superficial
femoral artery thrombosis in 1 patient (20%), and popliteal
artery thrombosis in 1 patient (20%). Except for the patient
with aortic thrombosis, the remaining patients had unilat-
eral lower extremity ischemic symptoms. All patients un-
derwent a thorough anticoagulation evaluation, which in-
cluded the following serum levels: protein C, protein S,
Table I. Clinical summary of patient characteristics, histor
Patient
Age
(y) Sex
Route and type
of cocaine usage
Hist
n
1 26 Male Cocaine
intranasal
inhalation
Mari
2 42 Male Smoking, crack
cocaine
Mari
am
3 49 Male Smoking crack
cocaine
Hero
ph
(PC
4 38 Female Cocaine
intranasal
inhalation
Mari
5 46 Male Smoking crack
cocaine
Herofactor V Leiden, homocysteine, lupus anticoagulant, anti-
cardiolipin antibody, and antithrombin III activity. More-
over, a hematology consultation was obtained to assist in
the hypercoagulation workup in all patients. Transesopha-
geal echocardiography was performed in all patients, and
showed no evidence of proximal cardiac source of arterial
embolism. Laboratory and diagnostic studies in these pa-
tients revealed no other cardiovascular or thrombotic risk
factors that would predispose to arterial occlusion. Table II
lists the treatment and outcome in these patients with
cocaine-induced arterial occlusion. Surgical thrombectomy
with a Fogarty embolectomy balloon via femoral artery
cutdown was successfully performed in 4 patients (80%).
Mean operative time was 74 minutes (range, 57-130 min-
utes). Completion arteriography was performed intraoper-
atively, and documented successful restoration of arterial
flow to the pedal vessels in these patients. In contrast, 1
patient with a popliteal artery embolism (20%) underwent
catheter-directed thrombolytic therapy via a contralateral
femoral approach. After 24 hours of intra-arterial infusion
of urokinase (Abbokinase, 1,200,000 units; Abbott), the
popliteal artery circulation was successfully restored with
palpable pedal pulses. All thrombi removed at surgical
thrombectomy were sent to the Pathology Department for
specimen analysis, which revealed platelet-rich thrombus
with mixed presence of fibrin and red blood cells. Drug
counseling was initiated in all patients before their dis-
charge. All patients were treated with intravenous heparin
followed by oral warfarin sodium for 6 months after the
thrombectomy or thrombolysis procedure. No periopera-
tive morbidity or mortality occurred in these patients. The
mean length of hospitalization was 4.5 days (range, 2-7
days).
All 5 patients who were discharged were available for
follow-up (mean, 36 months; range, 6-75 months). One
patient died of drug overdose 8 months later. There was 1
late death from myocardial infarction. In 1 patient recur-
rent lower extremity arterial thrombosis developed after 28
months, which was successfully treated with thrombolytic
therapy. At the time of the recurrent arterial thrombosis the
ther illicit drug usage, and site of arterial occlusion
other illicit
ic usage
Duration of cocaine
use and arterial
thrombosis (hr) Site of thrombosis
, heroin 16 Aorta
,
mine
3 Left common iliac
artery
lidine
2 Right external iliac
artery
20 Right superficial
femoral artery
5 Left popliteal arteryy of o
ory of
arcot
juana
juana
pheta
in,
encyc
P)
juana
in
JOURNAL OF VASCULAR SURGERY
Volume 40, Number 2 Zhou et al 293patient denied any cocaine use. After a 5-day hospitaliza-
tion, the patient was lost to subsequent follow-up.
DISCUSSION
This report is notable because it represents the largest
series of patients with cocaine-induced acute thrombosis
involving the peripheral arterial system. Moreover, our
series highlights the relatively young age of patients with
cocaine-induced arterial ischemia. The results of this study
demonstrate that immediate operative or endovascular in-
tervention can result in successful restoration of arterial
circulation. Despite initially successful interventions, none-
theless, habitual consumption of cocaine in several patients
likely resulted in other devastating consequences that ac-
counted for subsequent morbidity and mortality.
As the leading cause of drug-related deaths in the
United States, cocaine and its derivate, crack cocaine, are
the most commonly used illicit drugs among persons seek-
ing acute care in hospitals or drug treatment centers.5
Cocaine is an alkaloid extract from the leaves of Erythroxy-
lon coca plants growing primarily in South America. Co-
caine is prepared by dissolving the alkaloid coca extracts in
hydrochloric acid to form a water-soluble salt. In contrast,
crack cocaine is a more potent, basic non-salt derivative of
the cocaine alkaloid, which is prepared from ether solution.
Crack cocaine has gained increasing popularity among
drug users, because it can be readily manufactured at home
with simple laboratory apparatus.13 Moreover, the rapid
absorption of crack cocaine, when smoked, is facilitated by
the large respiratory absorptive surface.14 As a result, the
effect of smoking crack cocaine is nearly instantaneous and
extremely powerful. We postulate that this mechanism of
pharmacologic absorption may account in part for the
disparity in onset of arterial ischemia in our patients. Those
patients who smoked crack cocaine experienced a more
rapid onset of ischemic symptoms, in the range of 2 to 5
hours. In contrast, the 2 patients who inhaled cocaine
intranasally had delayed onset of ischemic symptoms, at 16
and 20 hours, respectively. Previous studies have demon-
strated that cocaine-induced arterial thrombosis in the cor-
onary circulation is associated with early onset of symp-
Table II. Treatment and outcome in patients with cocaine
Patient
Initial
treatment
Outcome after initial
treatment
1 Surgical
thrombectomy
Palpable pedal pulses
2 Surgical
thrombectomy
Palpable pedal pulses
3 Surgical
thrombectomy
Palpable pedal pulses
4 Surgical
thrombectomy
Palpable pedal pulses;
SFA occlusion 28
months later
5 Thrombolytic
therapy
Palpable pedal pulses
SFA, Superficial femoral artery; NA, not available.toms, in the range of 5 to 90 minutes.5,6,15 This rapid
temporal relationship was in sharp contrast to our patients,
who developed ischemic symptoms many hours after co-
caine usage. We believe the delayed onset of ischemic
symptoms was largely due to the diameter disparity com-
pared with the coronary circulation. Because a coronary
artery is typically less than 3 mm in diameter, rapid onset of
thrombosis is more likely to develop in the event of severe
vasoconstriction from cocaine ingestion. In all of our pa-
tients, on the other hand, the affected circulation was
peripheral vessels, such as aortoiliac or femoropopliteal
arteries, which have a much larger diameter than the coro-
nary circulation. Therefore a much longer duration took
place before arterial thrombosis occurred from cocaine-
induced vasoconstriction.
We postulate that cocaine was the main cause of arterial
thrombosis in our patients, as evidenced by the strong
temporal relationship between cocaine consumption and
onset of ischemic symptoms. It is noteworthy that none of
our patients had other cardiovascular or hematologic risk
factors for increased thrombotic propensity. Cocaine-in-
duced peripheral arterial occlusion has been described in
only 3 reports previously.10-12 Chen et al11 reported a
patient who inhaled cocaine intranasally and had multiple
arterial thromboses 8 hours later that involved the popli-
teal, hepatic, celiac, and splenic arteries. These were suc-
cessfully treated with a combination of systemic anticoag-
ulation, operative thrombectomy followed by femorotibial
bypass grafting, and delayed splenectomy. Another case
report described a patient in whom acute-onset lower leg
ischemia developed 1 hour after smoking crack cocaine.
Urgent angiography was performed, and revealed throm-
bosed iliac and popliteal arteries. Thrombolytic therapy was
instituted, which resulted in a successful outcome.10 Last,
Webber et al12 recently described 2 patients in whom aortic
thrombosis developed after they smoked crack cocaine.
One patient underwent operative aortic thrombectomy
through a thoracoabdominal approach, and the other pa-
tient was treated nonoperatively with systemic anticoagula-
tion. Both patients had a prolonged hospital course, but
ultimately were discharged to home with satisfactory out-
uced arterial occlusion
ubsequent
reatment
Follow-up
(mo) Outcome and follow-up
22 Died of myocardial
infarction 26 months later
75 No further thrombotic
episode
6 Died of drug overdose 8
months later
rombolytic
herapy
28 Lost to follow-up after
secondary treatment
48 No further thrombotic
episode-ind
S
t
NA
NA
NA
Th
t
NA
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underwent thorough diagnostic evaluations, which did not
identify any hematologic or cardiovascular risk factors that
predisposed to arterial thrombosis. More important, the
strong temporal correlation between cocaine consumption
and acute onset of arterial ischemia in all of these patients
underscores this unusual pharmacologic cause of arterial
thrombosis.
The precise mechanism of action of cocaine-induced
arterial thrombosis remains poorly defined. However, co-
caine exerts numerous physiologic effects, which may in
part account for the ischemic complications in these pa-
tients. Illicit cocaine use has been known to result in many
cardiovascular adverse effects, due largely to its central and
peripheral adrenergic stimulation, which influences arterial
circulation.5 The predominant action of cocaine is inhibi-
tion of the reuptake of dopamine and norepinephrine at
preganglionic sympathetic nerve endings, which potenti-
ates the effect of endogenous catecholamines, resulting in
arterial vasoconstriction and hypertension. This vasocon-
strictive effect of cocaine has been confirmed in a clinical
study in which quantitative coronary angiography was per-
formed in patients after intranasal cocaine consumption.15
The researchers found a significant reduction in coronary
blood flow and luminal diameter as a result of vasoconstric-
tion in patients treated with cocaine compared with pa-
tients treated with intranasal saline solution control.15
Platelet aggregation and subsequent release of its vaso-
active mediators is another potential mechanism of cocaine-
induced arterial thrombosis.16 Using human platelets and
animal studies, Kugelmass et al17,18 demonstrated that
intravenous cocaine administration activated circulating
platelets, as evidenced by the increased expression of P-
selectin, found on the surface of activated platelets. The
hypothesis of cocaine-induced platelet aggregation has
been similarly supported in numerous autopsy studies that
demonstrated acute occlusive thrombi composed predom-
inantly of platelets in peripheral and coronary arteries.19-21
Last, cocaine may induce arterial thrombosis by causing
endothelial cells to increase the release of endothelin, a
potent vasoconstrictor, and also to decrease the production
of nitric oxide, a powerful vasodilator.5,22 Using both
plethysmographic and angiographic assessment, Havranek
et al22 compared the endothelium-dependent vasorelax-
ation in response to intraarterial acetylcholine and nitro-
prusside administration in long-term cocaine users and
non-cocaine users. They found significantly impaired endo-
thelium-dependent vasorelaxation in the cocaine users
compared with the control group.
Once cocaine-induced arterial thrombosis is identified,
treatment strategies of thrombus removal and reestablish-
ment of arterial circulation can be performed with either
surgical thrombectomy or catheter-directed thrombolysis.
In all of our patients arteriograms revealed acute thrombo-
sis without underlying atherosclerosis or contralateral dis-
ease process. Operative thrombectomy is indicated in pa-
tients with large thrombus load or limb-threatening
ischemia, which mandate immediate thrombus removal.This treatment strategy successfully restored the arterial
circulation in 4 of our patients. Because balloon thrombo-
embolectomy was used in patients with arterial thrombosis
involving relatively large vessels, such as aorta, iliac, and
femoral arteries, we did not observe any significant vaso-
spasm after thrombectomy. In 1 patient with popliteal
artery thrombosis we chose catheter-directed thrombolysis
via a contralateral femoral approach, because of the throm-
bus burden in a small-caliber vessel. While this percutane-
ous approach provides a less invasive benefit, catheter-
directed thrombolysis may also obviate the potential
operative trauma associated with balloon thrombectomy.
Conservative management with systemic anticoagulation
may be considered in patients with no overt ischemic
symptoms, which was reported to be successful in a patient
with cocaine-induced aortic thrombosis.12
In conclusion, our study underscores that cocaine
abuse is a potential cause of acute arterial thrombosis.
Cocaine-induced arterial thrombosis should be suspected
in patients with a recent history of cocaine use who have
acute limb ischemia without overt cardiovascular risk fac-
tors. Physicians should have a high index of suspicion when
treating patients with a history of illicit cocaine consump-
tion who have arterial ischemia. With prompt diagnosis and
timely intervention, adequate revascularization, with limb
salvage, can be achieved in these patients.
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Submitted Feb 3, 2004; accepted Apr 29, 2004.CORRECTION
In: “Persistent sciatic artery as collateral for an occluded iliofemoral system” (Samson RH, Showalter DP.
J Vasc Surg 2004;40:183).
Due to an error during the publication process, the July 2004 cover was inadvertently published in black and
white. The figure on the cover should have been in color, and the correct version is reproduced below.
